@POGOwatchdog's Congressional Oversight Initiative: resources, expertise & training for investigations and oversight staff #PaperTrail
Washington, DC
Joined March 2015
- Tweets3.3K
- Following1K
- Followers1.3K
- Likes969
Pinned Tweet
Hi everyone! This account is going dormant today-- but don’t worry, you can still get oversight news and #PaperTrail updates at @POGOwatchdog, and follow us on LinkedIn to make sure you’re getting the latest updates about our COI programming and resources! linkedin.com/company/project…
In today's edition of #PaperTrail
Battle Over Jan. 6 Committee Rages On;
Kavanaugh Vetting Draws Fire;
Uber and Lyft Carjackings;
and More.
Costly Fumble: Capitol rioters on Jan. 6 came within 100 feet of the "nuclear football," prompting a Pentagon inspector general review of how the Presidential Emergency Satchel is kept safe and secure cnn.com/2021/07/20/politics/…
"They placed their lives in the hands of Uber’s and Lyft’s algorithms," writes @darakerr. There have been 124 carjackings of rideshare drivers in the last 18 months, and the companies are doing almost nothing to help themarkup.org/working-for-an…
In today's #PaperTrail:
DOJ Lets Officials Who Lied About Census Off the Hook;
Israeli Spyware Used to Hack Journalists, Activists;
Defense Industry Leads in Giving to Election Objectors;
and More.
Subscribe to all @POGOwatchdog's newsletters here: pogo.org/subscribe/
Flyin' High (In The Unfriendly Sky): @mikelaris & @loriara report the system for keeping the peace on U.S. airlines is "creaking under the pressure" of "an unprecedented proliferation of misbehavior" on flights washingtonpost.com/transport…
Meet Pegasus—a software tool developed by an Israeli firm that governments worldwide are using to hack smartphones. It's all part of the growing and largely unregulated private spyware industry washingtonpost.com/investiga…
In today's edition of #PaperTrail:
FBI Botched Nassar Abuse Probe;
Jan. 6 Committee Sets First Hearing;
Companies Take Advantage of Weakened IRS;
and More.
Industry says letting government negotiate lower drug prices would stifle innovation. But a congressional report found Big Pharma spends far more on stock buybacks, dividends, executive pay and stifling competition than on research & development thebrick.house/pharma-compan…
